Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma - Jiang, Ying; Sun, Aihua; Zhao, Yang; Ying, Wantao; Sun, Huichuan; Yang, Xinrong; Xing, Baocai; Sun, Wei; Ren, Liangliang; Hu, Bo; Li, Chaoying; Zhang, Li; et al. (Nature (London), 2019)
Keywords: 13/105; 13/51; 13/89; 631/45/475; 64/60; 692/699/67/1504/1610; 82/1; 82/16; 82/58; 82/81; Acids; Animals; Bioinformatics; Cancer; Cancer research; Carcinoma; Carcinoma, Hepatocellular - drug therapy; Carcinoma, Hepatocellular - metabolism; Carcinoma, Hepatocellular - pathology; Carcinoma, Hepatocellular - virology; Care and treatment; Cell adhesion & migration; Cell cycle; Cell Growth Processes; Cell Movement; Cholesterol; Criminal investigation; Gene expression; Genomes; Hepatitis; Hepatitis B; Hepatitis B virus; Hepatitis B virus - pathogenicity; Hepatocellular carcinoma; Heterogeneity; Homeostasis; Humanities and Social Sciences; Humans; Infection; Infections; Letter; Liver cancer; Liver Neoplasms - drug therapy; Liver Neoplasms - metabolism; Liver Neoplasms - pathology; Liver Neoplasms - virology; Male; Medical prognosis; Medical schools; Metastasis; Mice; Mice, Inbred NOD; Mice, SCID; Molecular Targeted Therapy - trends; multidisciplinary; Mutation; Neoplasm Staging; Phosphorylation; Physiological aspects; Principal components analysis; Prognosis; Proteins; Proteomics; Risk analysis; Risk factors; Science; Science (multidisciplinary); Steroids (Organic compounds); Sterol O-acyltransferase; Sterol O-Acyltransferase - genetics; Surgery; Survival; Target recognition; Therapeutic applications; Tumors; Virus diseases; Viruses; Xenografts; Xenotransplantation; United States--US